DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Pan X, Kachroo S, Liu X. et al.
Real world discontinuation among early users of apixaban, dabigatran, rivaroxaban or warfarin among atrial fibrillation patients newly initiated on anticoagulation therapy: Tell of first 200 days [abstract].
Eur Heart J [serial online] 2014;
35 (Abstract Supplement): 897
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.